Table 3.
Training | Validation | ||||
---|---|---|---|---|---|
Marker | AUC | p value1 | Invert2 | AUC | p value |
CEA | 0.615 | 0.01292 | 0.51 | 0.82743 | |
CA 125 | 0.586 | 0.06225 | 0.567 | 0.14861 | |
PPP2R4 | 0.633 | 0.00375 | Yes | 0.508 | 0.86407 |
RAC1 | 0.61 | 0.01718 | Yes | 0.53 | 0.51718 |
Sclerostin | 0.607 | 0.02106 | Yes | 0.567 | 0.1496 |
IL−12 p70 | 0.604 | 0.02416 | 0.54 | 0.38493 | |
IL−2 | 0.604 | 0.02385 | 0.583 | 0.07337 |
All markers with unadjusted p values less than 0.05 in the training phase are shown.
If “yes”, then the values were higher in the controls compared to cases.